1.Role of Notch signaling in regulating innate immunity and inflammation in health and disease.
Yingli SHANG ; Sinead SMITH ; Xiaoyu HU
Protein & Cell 2016;7(3):159-174
The Notch signaling pathway is conserved from Drosophila to mammals and is critically involved in developmental processes. In the immune system, it has been established that Notch signaling regulates multiple steps of T and B cell development in both central and peripheral lymphoid organs. Relative to the well documented role of Notch signaling in lymphocyte development, less is known about its role in regulating myeloid lineage development and function, especially in the context of acute and chronic inflammation. In this review article, we will describe the evidence accumulated during the recent years to support a key regulatory role of the Notch pathway in innate immune and inflammatory responses and discuss the potential implications of such regulation for pathogenesis and therapy of inflammatory disorders.
Animals
;
B-Lymphocytes
;
immunology
;
pathology
;
Humans
;
Inflammation
;
immunology
;
pathology
;
Receptors, Notch
;
immunology
;
Signal Transduction
;
immunology
;
T-Lymphocytes
;
immunology
;
pathology
2.Immune pathogenesis of IgA nephropathy and its drugable targets.
Liyu HE ; Hong LIU ; Youming PENG
Journal of Central South University(Medical Sciences) 2014;39(1):96-101
IgA nephropathy (IgAN) is recognized as the most common immune complex related to the cause of glomerulonephritis worldwide. The disease is characterized by the predominant deposition of underglycosylated IgA1 in the mesangial area of glomeruli. Dysregulation of the immune system plays an important role in the pathogenesis of IgAN. Abnormalities restricted to T lymphocytes and/or B lymphocytes activation could be a critical causative factor in the over-production of underglycosylated IgA1.
Antigen-Antibody Complex
;
B-Lymphocytes
;
Glomerular Mesangium
;
Glomerulonephritis, IGA
;
pathology
;
Humans
;
Immunoglobulin A
;
chemistry
;
T-Lymphocytes
4.The progress in prediction of cancer risk by cytokinesis-block micronucleus in peripheral blood lymphocytes.
Guanghui ZHANG ; Jingwen HUANG ; Xiaowen XU ; Jinwei WANG ; Dange LI ; Lingli YE ; Zhaolin XIA
Chinese Journal of Industrial Hygiene and Occupational Diseases 2014;32(5):391-394
Cytokinesis
;
Humans
;
Lymphocytes
;
pathology
;
Micronucleus Tests
;
Neoplasms
;
genetics
;
Risk Factors
5.Value of Pretreatment Inflammation-nutrition Score to Predict Non-response to Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer.
Guo Chao ZHANG ; Yan Yan XU ; Ying Chao WU ; Nuo CHENG ; Rui LIAN ; Xin WANG
Biomedical and Environmental Sciences 2023;36(10):940-948
OBJECTIVE:
To investigate the value of pretreatment inflammatory-nutritional biomarkers in predicting the pathological response of locally advanced rectal cancer (LARC) after neoadjuvant chemotherapy (nCT).
METHODS:
This retrospective study included eligible participants who underwent nCT followed by radical surgery. Pretreatment inflammatory nutritional biomarkers were calculated within one week prior to nCT. Correlations between biomarkers and pathological responses were analyzed. The cut-off values of the pretreatment biomarkers for predicting non-response were determined using receiver operating characteristic (ROC) curve analysis. The inflammation-nutrition score was calculated using the lymphocyte level, neutrophil-to-lymphocyte ratio (NLR), and prognostic nutritional index (PNI).
RESULTS:
A total of 235 patients were retrospectively recruited between January 2017 and September 2022. Lower lymphocyte levels, lymphocyte monocyte ratio (LMR), and PNI, and higher NLR and platelet-to-lymphocyte ratio (PLR) were observed in patients without response. Multivariate logistic regression analysis revealed that NLR could independently predict non-response to nCT in patients with LARC. The sensitivity and specificity of the inflammation-nutrition score for predicting nonresponse were 71.2% and 61.7%, respectively.
CONCLUSION
The pretreatment inflammation-nutrition score is a practical parameter for predicting non-response to nCT in patients with LARC. Patients with high scores were more likely to respond poorly to nCT.
Humans
;
Retrospective Studies
;
Neoadjuvant Therapy
;
Lymphocytes
;
Biomarkers
;
Rectal Neoplasms/pathology*
6.Apoptosis of peripheral blood cells of children with viral pneumonia.
Min HANG ; An-cun HOU ; Yan LU ; Xin-jia WANG
Chinese Journal of Experimental and Clinical Virology 2004;18(2):175-178
BACKGROUNDTo study apoptosis of peripheral blood cells of children with viral pneumonia, explore immunopathogenesis and the possibility of immunotherapy of patients with viral pneumonia.
METHODSFresh peripheral blood samples were collected from 28 patients with viral pneumonia and 24 healthy children were treated and run through the flow cytometry. The data were acquired using Cell Quest software and the percentage of live cells, viable apoptotic cells, non-viable apoptotic cells and dead cells of neutrophils and lymphocytes were counted. The patients with viral pneumonia were hospitalized at our hospital. The average age of patients was 1.3 years; 24 healthy children were served as control group (age 1.8 years, on average). T-test and variance analysis by SPSS FOR WINDOWS 10.0 software was used for statistical analysis.
RESULTSThe percentage of live neutrophils and lymphocytes in the acute stage and recovery stage in patients were significantly lower than that in control group (P < 0.01). The percentage of viable apoptotic neutrophils and lymphocytes in two stages in patients were significantly higher than that in control group (P < 0.05). Except for the percentage of live cells, non-viable apoptotic cells and dead lymphocytes, others had no difference between the patients and control groups.
CONCLUSIONApoptosis of neutrophils and lymphocytes of peripheral blood cells of children with viral pneumonia increased. Whereas the percentage of live cells decreased. Drugs that can accelerate apoptosis may be helpful in treatment of viral pneumonia.
Apoptosis ; Child, Preschool ; Female ; Flow Cytometry ; Humans ; Infant ; Lymphocytes ; pathology ; Male ; Neutrophils ; pathology ; Pneumonia, Viral ; pathology
7.Primary gastric B-cell lymphoblastic lymphoma: report of a case.
Miao-xia HE ; Xiong-zeng ZHU ; Wei-qiang LIU ; Li-li WU ; Ming-hua ZHU
Chinese Journal of Pathology 2008;37(6):420-421
Adult
;
B-Lymphocytes
;
pathology
;
Female
;
Humans
;
Lymphoma, B-Cell
;
pathology
;
Stomach Neoplasms
;
pathology
8.Guards at the gate: physiological and pathological roles of tissue-resident innate lymphoid cells in the lung.
Hang CHENG ; Chengyan JIN ; Jing WU ; Shan ZHU ; Yong-Jun LIU ; Jingtao CHEN
Protein & Cell 2017;8(12):878-895
The lung is an important open organ and the primary site of respiration. Many life-threatening diseases develop in the lung, e.g., pneumonia, asthma, chronic obstructive pulmonary diseases (COPDs), pulmonary fibrosis, and lung cancer. In the lung, innate immunity serves as the frontline in both anti-irritant response and anti-tumor defense and is also critical for mucosal homeostasis; thus, it plays an important role in containing these pulmonary diseases. Innate lymphoid cells (ILCs), characterized by their strict tissue residence and distinct function in the mucosa, are attracting increased attention in innate immunity. Upon sensing the danger signals from damaged epithelium, ILCs activate, proliferate, and release numerous cytokines with specific local functions; they also participate in mucosal immune-surveillance, immune-regulation, and homeostasis. However, when their functions become uncontrolled, ILCs can enhance pathological states and induce diseases. In this review, we discuss the physiological and pathological functions of ILC subsets 1 to 3 in the lung, and how the pathogenic environment affects the function and plasticity of ILCs.
Animals
;
Humans
;
Immunity, Innate
;
Lung
;
immunology
;
pathology
;
Lung Diseases
;
immunology
;
pathology
;
therapy
;
Lymphocytes
;
immunology
;
pathology
10.Lymphocytic Interstitial Pneumonia in Primary Sjogren's Syndrome: A Case Report.
Ji Young KIM ; Sung Hoon PARK ; Seong Kyu KIM ; Dae Sung HYUN ; Yoon Seup KUM ; Kyung Jae JUNG ; Jung Yoon CHOE
The Korean Journal of Internal Medicine 2011;26(1):108-111
Sjogren's syndrome (SS) is an autoimmune disorder in which lymphocytes infiltrate the exocrine glands, resulting in the development of sicca symptoms. Lymphocytes may also invade various other organs and cause diverse symptoms. Interstitial pneumonia has been observed frequently in SS patients. Typically, the pneumonia responds well to systemic steroids, and fatal cases are rare. We experienced a case of lymphocytic pneumonia accompanied by SS and treated with cyclophosphamide pulse therapy, and we present details of the case herein.
Adult
;
Humans
;
Lung/*pathology
;
Lung Diseases, Interstitial/drug therapy/*pathology
;
Lymphocytes/*pathology
;
Male
;
Plasma Cells/pathology
;
Sjogren's Syndrome/*pathology